695 related articles for article (PubMed ID: 32727810)
1. Small molecule AZD4635 inhibitor of A
Borodovsky A; Barbon CM; Wang Y; Ye M; Prickett L; Chandra D; Shaw J; Deng N; Sachsenmeier K; Clarke JD; Linghu B; Brown GA; Brown J; Congreve M; Cheng RK; Dore AS; Hurrell E; Shao W; Woessner R; Reimer C; Drew L; Fawell S; Schuller AG; Mele DA
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727810
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Combination Strategies for the A
Voronova V; Peskov K; Kosinsky Y; Helmlinger G; Chu L; Borodovsky A; Woessner R; Sachsenmeier K; Shao W; Kumar R; Pouliot G; Merchant M; Kimko H; Mugundu G
Front Immunol; 2021; 12():617316. PubMed ID: 33737925
[TBL] [Abstract][Full Text] [Related]
3. Overcoming high level adenosine-mediated immunosuppression by DZD2269, a potent and selective A2aR antagonist.
Bai Y; Zhang X; Zheng J; Liu Z; Yang Z; Zhang X
J Exp Clin Cancer Res; 2022 Oct; 41(1):302. PubMed ID: 36229853
[TBL] [Abstract][Full Text] [Related]
4. Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103
Zhou Y; Slone N; Chrisikos TT; Kyrysyuk O; Babcock RL; Medik YB; Li HS; Kleinerman ES; Watowich SS
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32273347
[TBL] [Abstract][Full Text] [Related]
5. Non-small Cell Lung Cancer Cells Modulate the Development of Human CD1c
Lu Y; Xu W; Gu Y; Chang X; Wei G; Rong Z; Qin L; Chen X; Zhou F
Front Immunol; 2019; 10():2829. PubMed ID: 31921114
[TBL] [Abstract][Full Text] [Related]
6. Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.
Salmon H; Idoyaga J; Rahman A; Leboeuf M; Remark R; Jordan S; Casanova-Acebes M; Khudoynazarova M; Agudo J; Tung N; Chakarov S; Rivera C; Hogstad B; Bosenberg M; Hashimoto D; Gnjatic S; Bhardwaj N; Palucka AK; Brown BD; Brody J; Ginhoux F; Merad M
Immunity; 2016 Apr; 44(4):924-38. PubMed ID: 27096321
[TBL] [Abstract][Full Text] [Related]
7. A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor Microenvironment.
Mediavilla-Varela M; Castro J; Chiappori A; Noyes D; Hernandez DC; Allard B; Stagg J; Antonia SJ
Neoplasia; 2017 Jul; 19(7):530-536. PubMed ID: 28582704
[TBL] [Abstract][Full Text] [Related]
8. CD103 (αE Integrin) Undergoes Endosomal Trafficking in Human Dendritic Cells, but Does Not Mediate Epithelial Adhesion.
Swain S; Roe MM; Sebrell TA; Sidar B; Dankoff J; VanAusdol R; Smythies LE; Smith PD; Bimczok D
Front Immunol; 2018; 9():2989. PubMed ID: 30622531
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models.
Leone RD; Sun IM; Oh MH; Sun IH; Wen J; Englert J; Powell JD
Cancer Immunol Immunother; 2018 Aug; 67(8):1271-1284. PubMed ID: 29923026
[TBL] [Abstract][Full Text] [Related]
10. Mesenteric lymph node CD11b
Shiokawa A; Kotaki R; Takano T; Nakajima-Adachi H; Hachimura S
Immunology; 2017 Sep; 152(1):52-64. PubMed ID: 28423181
[TBL] [Abstract][Full Text] [Related]
11. A
Kjaergaard J; Hatfield S; Jones G; Ohta A; Sitkovsky M
J Immunol; 2018 Jul; 201(2):782-791. PubMed ID: 29802128
[TBL] [Abstract][Full Text] [Related]
12. Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells.
Iliev ID; Spadoni I; Mileti E; Matteoli G; Sonzogni A; Sampietro GM; Foschi D; Caprioli F; Viale G; Rescigno M
Gut; 2009 Nov; 58(11):1481-9. PubMed ID: 19570762
[TBL] [Abstract][Full Text] [Related]
13. Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors.
Lim EA; Bendell JC; Falchook GS; Bauer TM; Drake CG; Choe JH; George DJ; Karlix JL; Ulahannan S; Sachsenmeier KF; Russell DL; Moorthy G; Sidders BS; Pilling EA; Chen H; Hattersley MM; Das M; Kumar R; Pouliot GP; Patel MR
Clin Cancer Res; 2022 Nov; 28(22):4871-4884. PubMed ID: 36044531
[TBL] [Abstract][Full Text] [Related]
14. The Emerging Role of CD8
Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F
Front Immunol; 2018; 9():1904. PubMed ID: 30158938
[TBL] [Abstract][Full Text] [Related]
15. Liver-resident CD103+ dendritic cells prime antiviral CD8+ T cells in situ.
Krueger PD; Kim TS; Sung SS; Braciale TJ; Hahn YS
J Immunol; 2015 Apr; 194(7):3213-22. PubMed ID: 25712214
[TBL] [Abstract][Full Text] [Related]
16. Co-immunization with L-Myc enhances CD8
Chai D; Zhang Z; Jiang N; Ding J; Qiu D; Shi SY; Wang G; Fang L; Li H; Tian H; Yang J; Zhang Q; Zheng J
Cancer Sci; 2021 Sep; 112(9):3469-3483. PubMed ID: 34157192
[TBL] [Abstract][Full Text] [Related]
17. CD103
Miao X; Chen Y; Hao K; Zheng M; Chen B; Li K; Wang Y; Zhang W; Zhang Y; Mou X; Jiang S; Wang Z
Oncol Res; 2018 Mar; 26(2):173-182. PubMed ID: 28109087
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid-loaded liposomes induce human mucosal CD103
Nagy NA; Hafkamp FMJ; Sparrius R; Bas R; Lozano Vigario F; van Capel TMM; van Ree R; Geijtenbeek TBH; Slütter B; Tas SW; de Jong EC
Eur J Immunol; 2024 May; 54(5):e2350839. PubMed ID: 38430190
[TBL] [Abstract][Full Text] [Related]
19. MyD88 Signaling Regulates Steady-State Migration of Intestinal CD103+ Dendritic Cells Independently of TNF-α and the Gut Microbiota.
Hägerbrand K; Westlund J; Yrlid U; Agace W; Johansson-Lindbom B
J Immunol; 2015 Sep; 195(6):2888-99. PubMed ID: 26259586
[TBL] [Abstract][Full Text] [Related]
20. Genetic and pharmacological targeting of A2a receptor improves function of anti-mesothelin CAR T cells.
Masoumi E; Jafarzadeh L; Mirzaei HR; Alishah K; Fallah-Mehrjardi K; Rostamian H; Khakpoor-Koosheh M; Meshkani R; Noorbakhsh F; Hadjati J
J Exp Clin Cancer Res; 2020 Mar; 39(1):49. PubMed ID: 32151275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
